Biological Anti-IL-5/IL-5R Therapeutics for Chronic Obstructive Pulmonary Disease (COPD) with Specific Treatable Traits: A Real-World Retrospective Analysis.

Forest Day de LarrañagaAlexandre JoubertIsabelle DrouinIsabelle OuelletPei Zhi LiBryan A RossCarolyn J BagloleJean Bourbeau

Published in: International journal of chronic obstructive pulmonary disease (2024)

This real-world evidence data aligns with existing studies suggesting the potential benefit of anti-IL-5 treatment for specific patients with COPD and therefore advocates for further investigation of RCTs on the use of anti-IL-5 biologics for well-characterized patients with COPD.

Keyphrases

chronic obstructive pulmonary disease
lung function
small molecule
risk assessment
deep learning
big data
human health
artificial intelligence
replacement therapy